VDRM Company Profile and Key Details

Q: Who are the executives of VDRM?

Mr. Shaowen ZhangMang. of ProductionMr. Qing Hua LinChief Financial Officer and DirectorMr. Baotang ZhaoChief Sales OfficerMr. Zhang XieCorporation Sec. and DirectorDr. Christopher A OtikoFounder, Chief Executive Officer and PresDr. Andrew Berman M.D., MPHMedical Director and Member of Advisory Board

PNK : VDRM

ViaDerma

$0.01

0.0004+7.14%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

ViaDerma, Inc. (VDRM) stock surged +25.00%, trading at $0.00 on OTC, up from the previous close of $0.00. The stock opened at $0.00, fluctuating between $0.00 and $0.00 in the recent session.

Stock Snapshot

0.0004

Prev. Close

616.86K

Market Cap

0.0005

Day Low

-1.85

P/E Ratio

-0.00027

EPS (TTM)

Cash Flow per Share

Open

1.23B

Number of Shares

0.0005

Day High

10.18%

Free Float in %

Book Value

217.21K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	0.00	0.00	0.00	0.00	436.98K
Sep 09, 2026	0.00	0.00	0.00	0.00	5.13K
Sep 08, 2026	0.00	0.00	0.00	0.00	212.15K
Sep 02, 2026	0.00	0.00	0.00	0.00	4.1K
Sep 01, 2026	0.00	0.00	0.00	0.00	5K
Aug 25, 2026	0.00	0.00	0.00	0.00	7.51K
Aug 24, 2026	0.00	0.00	0.00	0.00	400
Aug 18, 2026	0.00	0.00	0.00	0.00	20K
Aug 17, 2026	0.00	0.00	0.00	0.00	111.38K
Aug 10, 2026	0.00	0.00	0.00	0.00	344.44K
Aug 06, 2026	0.00	0.00	0.00	0.00	22K
Aug 04, 2026	0.00	0.00	0.00	0.00	107K
Aug 03, 2026	0.00	0.00	0.00	0.00	160.2K
Jul 31, 2026	0.00	0.00	0.00	0.00	10K
Jul 16, 2026	0.00	0.00	0.00	0.00	110K
Jul 15, 2026	0.00	0.00	0.00	0.00	200
Jul 13, 2026	0.00	0.00	0.00	0.00	825.23K
Jul 10, 2026	0.00	0.00	0.00	0.00	3K
Jul 09, 2026	0.00	0.00	0.00	0.00	40K
Jul 08, 2026	0.00	0.00	0.00	0.00	3K

Contact Details

Las Vegas, NV 89119

United States

https://viaderma.com 310 496 5744

About Company

ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products. It also licenses its proprietary technology to other companies within the pharmaceutical sector, addressing various therapeutic areas. The company's primary offering is Vitastem, a topical antibiotic containing tetracycline, effective for treating a broad spectrum of ailments such as cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. Beyond its established products, ViaDerma is dedicated to expanding its pipeline, with ongoing development in fields including advanced topical antibiotics, antifungal treatments for toenails, diabetic amputation recovery, general acne, psoriasis, eczema, burn care, anti-aging and wrinkle-reducing formulations, medical cannabis applications, male pattern baldness, skin cancer, erectile dysfunction, and pain management. Established in 2007, the company operated as Décor Products International, Inc. until its renaming to ViaDerma, Inc. in May 2014. Its corporate operations are directed from Marina Del Rey, California.

Stock Peers

MKGAF

-6.5-3.38%

MERCK Kommanditgesellschaft auf Aktien$186.00 HKMPY

-0.87-1.69%

Hikma Pharmaceuticals PLC$50.66 SGIOF

Shionogi & Co., Ltd.$43.89 ESALF

Eisai Co., Ltd.$43.00 MKKGY

-0.85-2.24%

MERCK Kommanditgesellschaft auf Aktien$37.11 IPSEY

Ipsen S.A.$33.00 TKPHF

Takeda Pharmaceutical Company Limited$26.83 OCTVV

Octave Intelligence plc$17.48 TEVJF

5.26+43.91%

Teva Pharmaceutical Industries Limited$17.24 APNHY

Aspen Pharmacare Holdings Limited$12.52

Company Overview

The stock is currently mid-range between its 52-week high and low $0.00 and $0.01. With a market capitalization of about $616.86 thousand, ViaDerma, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.20). Key stats such as the average daily volume over the past year has been around 101.83 thousand shares, trading with heavier-than-usual volume. Headquartered in Las Vegas, NV, ViaDerma, Inc. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Christopher A Otiko, the company employs approximately 75 people and listed since October 31, 2014. ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products.

Technical Performance

Average 10-day trading volume of 132.67 thousand shares is in line with the 3-month average of 134.54 thousand, indicating normal recent market interest.

Valuation Metrics

ViaDerma, Inc. trades at a P/E ratio of 143.71, slightly above the S&P 500 average, with a price-to-sales ratio of 1.03 and a price-to-book ratio of 4.78 trading at moderately above to book value. The P/FCF stands at 3524.89, also above market averages.

Dividend & Fair Value

ViaDerma, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.01. This means the shares are trading below this model’s fair value.

Financial & Profitability Overview

Over the trailing twelve months, ViaDerma generated $600.50K in revenue, or $0.00 per share. Gross margin was 99.97%, operating margin 30.85%, and net profit margin 0.68%. Returns are modest, with ROA at 0.32% and ROE at 3.33%.
On valuation metrics, ViaDerma trades at a P/E of 143.71, P/S of 1.03 and P/B of 4.78. The current ratio is 1.10 and quick ratio is 1.10. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -32004.40 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 2.62, supported by a cash flow-to-debt ratio of 0.00.

Quarterly Financial Highlights

Gross profit was $600.30K (margin 99.97%). Operating income was $185.27K (margin 30.9%). Net income was$4.10K (EPS $0.00).
The company ended the quarter with $10.24K in cash and short-term investments, a total debt of $322.94K, and net debt of $312.70K. Total assets were $1.28M, with equity of $123.15K. Financials further reflected stability, with operating cash flow of $175.00, free cash flow of $175.00, and capital expenditures of $0.00.

Price Forecast & Outlook

Our AI price prediction model suggests that ViaDerma, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows ViaDerma, Inc. trading at a premium to the broader market with a P/E of 143.71.

Frequently Asked Questions

What is the current ViaDerma, Inc. (VDRM) stock price?

ViaDerma, Inc. (OTC: VDRM) stock price is $0.00 in the last trading session. During the trading session, VDRM stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in VDRM stock occurred in the recent session was 25% while the dollar amount for the price change in VDRM stock was $0.00.

VDRM's industry and sector of operation?

The OTC listed VDRM is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. ViaDerma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VDRM?

Mr. Shaowen Zhang
Mang. of Production
Mr. Qing Hua Lin
Chief Financial Officer and Director
Mr. Baotang Zhao
Chief Sales Officer
Mr. Zhang Xie
Corporation Sec. and Director
Dr. Christopher A Otiko
Founder, Chief Executive Officer and Pres
Dr. Andrew Berman M.D., MPH
Medical Director and Member of Advisory Board

How VDRM did perform over past 52-week?

VDRM's closing price is 20% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.01 is -66.67%.

How many employees does VDRM have?

Number of VDRM employees currently stands at 75.

Link for VDRM official website?

Official Website of VDRM is: https://viaderma.com

How do I contact VDRM?

VDRM could be contacted at phone 310 496 5744 and can also be accessed through its website. VDRM operates from 1050 E Flamingo Rd, Las Vegas, NV 89119, United States.

How many shares of VDRM are traded daily?

VDRM stock volume for the day was 217.21K shares. The average number of VDRM shares traded daily for last 3 months was 101.83K.

What is the market cap of VDRM currently?

The market value of VDRM currently stands at $616.86K with its latest stock price at $0.00 and 1.23B of its shares outstanding.

Employees	75
Beta	0.2
Sales or Revenue	$600.50K
5Y Sales Change%	5.762%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

VDRM Company Profile and Key Details

ViaDerma

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Price Forecast & Outlook

Technical Performance

Valuation Metrics

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Key Takeaways